Hwang Shen-An, Dasgupta Amitava, Actor Jeffrey K
Program in Molecular Pathology, Graduate School of Biomedical Sciences at the University of Texas Health Science Center, Houston, TX 77030, USA.
Clin Chim Acta. 2004 May;343(1-2):161-6. doi: 10.1016/j.cccn.2004.01.011.
Echinacea is commonly used in oral dosage as an immune stimulant to increase resistance to viral, bacterial and fungal infections of the upper respiratory tract. It has been suggested that Echinacea is able to stimulate innate immune responses, including those regulated by macrophages and natural killer cells. Indeed, macrophages respond to purified polysaccharide and alkylamide preparations. However, the mechanisms for stimulation of cells responsible for adaptive immunity have not been fully elucidated for other molecules present in Echinacea purpurea preparations.
Adherent and non-adherent mouse splenocyte populations were incubated in vitro with Echinacea, or with water or alcohol soluble Echinacea extract preparations. Supernatants were collected at 48-h post-incubation, and tested by standard ELISA for presence of secreted cytokines and proinflammatory mediators.
Whole splenocyte populations were capable of producing significant amounts IL-6 (1014 pg/ml) in response to Echinacea preparations. The response was primarily contained towards products isolated to the water extract preparation; no IL-6 was produced upon challenge with the alcohol extract. The IL-6 response was produced by the non-adherent cellular population, which made 4912 pg/ml IL-6 when treated with water soluble extract at 1 mg/ml. Likewise, the water soluble extract of Echinacea was able to stimulate non-adherent splenocyte populations to produce TNF-alpha (2082 pg/ml), IL-10 (892 pg/ml) and MIP-1alpha (6486 pg/ml) from non-adherent splenocytes, but only significant concentrations of TNF-alpha and MIP-1alpha mediators were produced from adherent populations at similar dose concentrations. Neither population of splenocytes was capable of stimulating significant production of IFN-gamma, IL-2 or IL-12 to any preparation of Echinacea examined.
The immune stimulatory ability of components contained within E. purpurea extracts offer insight into possible therapeutic potential of this product to regulate non-adherent lymphocytes in immune responses and activation events.
紫锥菊通常以口服剂量用作免疫刺激剂,以增强对上呼吸道病毒、细菌和真菌感染的抵抗力。有人提出紫锥菊能够刺激先天免疫反应,包括由巨噬细胞和自然杀伤细胞调节的免疫反应。事实上,巨噬细胞对纯化的多糖和烷基酰胺制剂有反应。然而,对于紫锥菊制剂中存在的其他分子,刺激负责适应性免疫的细胞的机制尚未完全阐明。
将贴壁和非贴壁小鼠脾细胞群体与紫锥菊或紫锥菊水或醇溶性提取物制剂在体外孵育。孵育48小时后收集上清液,并通过标准酶联免疫吸附测定法检测分泌的细胞因子和促炎介质的存在。
整个脾细胞群体能够对紫锥菊制剂产生大量的白细胞介素-6(1014皮克/毫升)。这种反应主要针对水提取物制剂中分离出的产物;用醇提取物刺激时不产生白细胞介素-6。白细胞介素-6反应由非贴壁细胞群体产生,当用1毫克/毫升的水溶性提取物处理时,该群体产生4912皮克/毫升的白细胞介素-6。同样,紫锥菊的水溶性提取物能够刺激非贴壁脾细胞群体产生肿瘤坏死因子-α(2082皮克/毫升)、白细胞介素-10(892皮克/毫升)和巨噬细胞炎性蛋白-1α(6486皮克/毫升),但在相似剂量浓度下,只有贴壁细胞群体产生显著浓度的肿瘤坏死因子-α和巨噬细胞炎性蛋白-1α介质。两种脾细胞群体均不能对所检测的任何紫锥菊制剂刺激产生显著量的干扰素-γ、白细胞介素-2或白细胞介素-12。
紫锥菊提取物中所含成分的免疫刺激能力为该产品在免疫反应和激活事件中调节非贴壁淋巴细胞的潜在治疗潜力提供了见解。